Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 12/20 | 0.49 |
| ▸ | FNTB | P49356 | 12/20 | 0.49 |
| ▸ | CTSD | P07339 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31458780 | 0.84 | OPRM1 (0.46) | CTSDBACE1OPRM1OPRD1OPRK1 | |
| SCHEMBL29550598 | 0.84 | BACE1 (0.45) | FNTAFNTBCTSDBACE1 | |
| SCHEMBL31721789 | 0.84 | OPRM1 (0.60) | FNTAFNTBOPRM1OPRD1OPRK1 | |
| SCHEMBL29445196 | 0.82 | BACE1 (0.46) | FNTAFNTBCTSDBACE1 | |
| SCHEMBL10873463 | 0.82 | OPRM1 (0.48) | CTSDBACE1OPRM1OPRD1OPRK1 | |
| SCHEMBL10873455 | 0.82 | OPRM1 (0.48) | CTSDBACE1OPRM1OPRD1OPRK1 | |
| SCHEMBL29688977 | 0.80 | FNTA (0.42) | FNTAFNTBCTSDBACE1 | |
| SCHEMBL31195687 | 0.78 | OPRM1 (0.50) | FNTAFNTBCTSDBACE1PGGT1B | |
| SCHEMBL30272493 | 0.78 | FNTA (0.44) | FNTAFNTBPGGT1BOPRM1OPRD1 | |
| SCHEMBL31195722 | 0.78 | OPRM1 (0.50) | CTSDBACE1OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220175955-A1 | PEPTIDE DISPLAY TO ANTIGEN PRESENTING CELLS USING LIPID VEHICLE | DANMARKS TEKNISKE UNIVERSITET (DK) | 2022-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220175955-A1 | PEPTIDE DISPLAY TO ANTIGEN PRESENTING CELLS USING LIPID VEHICLE | CD74, MICA, TAP1 | FNTA 1636/4885FNTB 1345/4885CTSD 232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.